Novavax
NVAX
#5502
Rank
NZ$2.27 B
Marketcap
NZ$13.94
Share price
-1.47%
Change (1 day)
32.72%
Change (1 year)

Novavax (NVAX) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : NZ$2.26 Billion

According to Novavax's latest financial reports the company's total liabilities are NZ$2.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novavax - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$2.25 B-41.85%
2024-12-31NZ$3.87 B-2.59%
2023-12-31NZ$3.97 B-12.74%
2022-12-31NZ$4.55 B6.27%
2021-12-31NZ$4.28 B223.83%
2020-12-31NZ$1.32 B148.39%
2019-12-31NZ$0.53 B-4.89%
2018-12-31NZ$0.56 B-1.54%
2017-12-31NZ$0.56 B-1.4%
2016-12-31NZ$0.57 B323.13%
2015-12-31NZ$0.13 B130.44%
2014-12-31NZ$59.19 M52.54%
2013-12-31NZ$38.8 M44.42%
2012-12-31NZ$26.87 M64.78%
2011-12-31NZ$16.3 M-20.35%
2010-12-31NZ$20.47 M-5.01%
2009-12-31NZ$21.55 M-59.83%
2008-12-31NZ$53.65 M45.6%
2007-12-31NZ$36.84 M-6.87%
2006-12-31NZ$39.56 M-22.13%
2005-12-31NZ$50.81 M-18.91%
2004-12-31NZ$62.66 M-15.52%
2003-12-31NZ$74.17 M-21.47%
2002-12-31NZ$94.45 M-1.01%
2001-12-31NZ$95.41 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
NZ$111.90 B 4,837.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$210.93 B 9,206.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$113.56 B 4,910.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$105.68 B 4,563.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$3.83 B 69.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$96.99 M-95.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.89 B-60.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$2.05 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$1.10 B-51.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.52 B-32.64%๐Ÿ‡บ๐Ÿ‡ธ USA